AIM: The genes were divided into seven categories according to biological function; apoptosis-related, immune response-related, signal transduction-related, cell cycle-related, cell growth-related, stress response-related and transcription-related genes. METHODS: We compared the gene expression profiles of SNU-C4 cells between amygdalin-treated (5 mg/mL, 24 h) and non-treated groups using cDNA microarray analysis. We selected genes downregulated in cDNA microarray and investigated mRNA levels of the genes by RT-PCR. RESULTS: Microarray showed that amygdalin downregulated especially genes belonging to cell cycle category: exonuclease 1 (EXO1), ATP-binding cassette, sub-family F, member 2 (ABCF2), MRE11 meiotic recombination 11 homolog A (MRE11A), topoisomerase (DNA) I (TOP1), and FK506 binding protein 12-rapamycin-associated protein 1 (FRAP1). RT-PCR analysis revealed that mRNA levels of these genes were also decreased by amygdalin treatment in SNU-C4 human colon cancer cells. CONCLUSION: These results suggest that amygdalin have an anticancer effect via downregulation of cell cycle-related genes in SNU-C4 human colon cancer cells, and might be used for therapeutic anticancer drug.
AIM: The genes were divided into seven categories according to biological function; apoptosis-related, immune response-related, signal transduction-related, cell cycle-related, cell growth-related, stress response-related and transcription-related genes. METHODS: We compared the gene expression profiles of SNU-C4 cells between amygdalin-treated (5 mg/mL, 24 h) and non-treated groups using cDNA microarray analysis. We selected genes downregulated in cDNA microarray and investigated mRNA levels of the genes by RT-PCR. RESULTS: Microarray showed that amygdalin downregulated especially genes belonging to cell cycle category: exonuclease 1 (EXO1), ATP-binding cassette, sub-family F, member 2 (ABCF2), MRE11 meiotic recombination 11 homolog A (MRE11A), topoisomerase (DNA) I (TOP1), and FK506 binding protein 12-rapamycin-associated protein 1 (FRAP1). RT-PCR analysis revealed that mRNA levels of these genes were also decreased by amygdalin treatment in SNU-C4 human colon cancer cells. CONCLUSION: These results suggest that amygdalin have an anticancer effect via downregulation of cell cycle-related genes in SNU-C4 human colon cancer cells, and might be used for therapeutic anticancer drug.
Authors: D M Wilson; J P Carney; M A Coleman; A W Adamson; M Christensen; J E Lamerdin Journal: Nucleic Acids Res Date: 1998-08-15 Impact factor: 16.971
Authors: Eun J Kim; Beverly S Schaffer; Young-hee Kang; Richard G Macdonald; Jung Hy Park Journal: J Gastroenterol Hepatol Date: 2002-05 Impact factor: 4.029
Authors: Anne Laurence Astier; Ronghui Xu; Marek Svoboda; Esther Hinds; Olivier Munoz; Rosalie de Beaumont; Colin Daniel Crean; Theodore Gabig; Arnold Stephen Freedman Journal: Blood Date: 2002-09-19 Impact factor: 22.113
Authors: Katja Ester; Fran Supek; Kristina Majsec; Marko Marjanović; David Lembo; Manuela Donalisio; Tomislav Šmuc; Ivana Jarak; Grace Karminski-Zamola; Marijeta Kralj Journal: Invest New Drugs Date: 2010-11-03 Impact factor: 3.850
Authors: Jasmina Makarević; Jochen Rutz; Eva Juengel; Silke Kaulfuss; Michael Reiter; Igor Tsaur; Georg Bartsch; Axel Haferkamp; Roman A Blaheta Journal: PLoS One Date: 2014-08-19 Impact factor: 3.240